Results showed that AKAP12 might be involved in cell cycle and immune regulation in bladder cancer progression for the observed enrichment of G2M checkpoint and interferon α/γ response pathway in low AKAP12 expression group (Figure 12C). Here, AKAP12 is linked to urinary bladder carcinoma.